Fullerton Health Announces a Significant Investment from Ping An Capital

Food and Healthcare Press Releases Tuesday November 28, 2017 08:30
SHANGHAI--28 Nov--PRNewswire/InfoQuest

Fullerton Healthcare Corporation Limited ("Fullerton Health" or the "Group"), a leading provider of corporate healthcare solutions across Asia Pacific, today announced a significant investment from Ping An Capital Co., Ltd. ("Ping An Capital"), the core equity investment platform of Ping An Insurance (Group) Company of China, Ltd ("Ping An of China").

To provide more affordable and accessible healthcare to its people, China has been reforming its healthcare system, starting with increasing medical spending, building capacity at the grassroots level and gradually increasing focus on supply side reform, reducing costs and improving efficiency.

David Sin, Deputy Chairman, Fullerton Health commented: "This partnership is an important milestone for Fullerton Health in China. Together with its related parties, the investment team of Ping An Capital led an investment of more than RMB 800 million into Fullerton, further cementing our relationship with Ping An of China. With the investment, Ping An Capital and its related parties have become Fullerton's second largest shareholder. The partnership offers a broad platform for Fullerton Health to expand our presence in the growing Chinese enterprise healthcare market."

Dr. Michael Tan, Co-Founder and Group CEO of Fullerton Health commented: "With the deepening of China's healthcare reform, there is no better time for Fullerton Health to expand into the Chinese market. As a leading provider of corporate healthcare solutions in the Asia Pacific region with a proven track record, Fullerton Health is uniquely positioned to offer quality healthcare that is affordable and accessible in China. Working closely with our China partners, we look forward to using our expertise to meet the ever-increasing demands of the Chinese healthcare market."

Although China's private healthcare market is still in its early stages of development, it has great potential due to the country's rapid economic growth, favourable demographic changes, and low penetration rate of the existing enterprise healthcare service market. According to a 2016 Frost & Sullivan research report, China's market for enterprise healthcare management will grow from $5.7 billion in 2010 to $21.1 billion in 2020.

Fullerton Health focuses on delivering enterprise healthcare services and currently serves over 25,000 companies. As a first step for its mainland China operations, Fullerton Health plans to establish approximately 100 clinics in major cities of Beijing, Shanghai and Guangzhou.

Liu Dong, Principal Partner of Ping An Capital commented, "Fullerton Health provides comprehensive medical services across five countries and regions in the Asia Pacific region. As Ping An of China's core equity investment platform, Ping An Capital's investment into Fullerton Health paves the way for Fullerton Health to adapt its well-established business model in mainland China. In addition to capital investment, Ping An Capital will leverage healthcare resources from Ping An of China, including Ping An health insurance, Ping An Good Doctor and Ping An Wanjia Healthcare to help boost Fullerton Health's business expansion in mainland China."

Ping An Insurance (Group) Company of China, Ltd., the controlling shareholder of Ping An Capital, became the world's largest insurer by market value in 2017. In the first half of 2017, Ping An's life and health insurance new business value reached nearly RMB38.5 billion, a robust growth of 46.2% year-on-year. The company has also been making consistent investments in the healthcare sector. Via the online "Ping An Good Doctor" health management platform and the offline "Ping An Wanjia Healthcare" health service chain, Ping An has connected hospitals, clinics, doctors, drug stores, check-up centers and other medical institutions to provide patients with comprehensive healthcare services. As of May 2017, Ping An Good Doctor provided health management services to 160 million Chinese users.

Media Contact:
Brunswick Group
Will Carnwath
Ben Fry
FullertonHealth@brunswickgroup.com
+65-6426-8188

Latest Press Release

Merck Receives Patent for CRISPR Technology in China

- Patent in China covers integration of an external DNA sequence into the chromosome of eukaryotic cells - Company to license CRISPR-related patents to interested parties, supports genome-editing research under ethical and legal standards -...

Cell and Gene Therapy Catapult Opens Manufacturing Centre to Accelerate Growth of the Industry in the UK

- Centre will 'bridge the gap' between scientific research and commercialisation of the medicines of the future - Over GBP60 million of Industrial Strategy investment is being used to develop the new centre Today,the Cell and Gene Therapy Catapult's...

Creation of Inceptua Clinical Trial Services Marks New Era for the Company

Inceptua Group (previously Multipharma) today announces that its Clinical Trial Supplies business unit is rebranding to Inceptua Clinical Trial Services. Going forward, all of the group's three business units including Clinical Trial Services, Medicines...

FDI White Paper and Practical Guide Address the Global Burden of Periodontal Disease

FDI World Dental Federation published two resources - a white paper and a practical guide - as part of its Global Periodontal Health Project (GPHP), which aims to bring attention to periodontal health as a priority area for policy worldwide. (Logo:...

New Research Shows Significant Benefits for COPD Patients in the Home Using Fisher Paykel Healthcare#s myAirvo

Fisher & Paykel Healthcare Corporation Limited announced today that new research has been published in the International Journal of COPD which demonstrates significant benefits of nasal high flow therapy for COPD* patients using Fisher & Paykel...

Related Topics